结核性脉络膜炎抗结核治疗启动共识指南
由COTS联合国际眼炎症学会和国际葡萄膜炎研究组组织的国际专家共识,采用系统综述和改良德尔菲法,针对结核性匍行样脉络膜炎、结核瘤和结核性局灶或多灶性脉络膜炎三种亚型,制定了关于何时启动抗结核治疗的共识声明,并涵盖辅助治疗建议。
要点
- 免疫学试验任一阳性且影像学提示结核时,专家共识同意启动抗结核治疗。
- 匍行样脉络膜炎和结核瘤中,即使无影像学结核特征,任一免疫学试验阳性也足以推荐治疗。
核心结论
- 共识指南基于文献、专家意见和实践经验制定,旨在指导结核性脉络膜炎患者启动抗结核治疗,弥合临床需求与现有医学证据之间的差距。
研究设计与样本
- 国际专家指导分委员会识别临床问题并对已发表文献进行系统综述,使用在线问卷,由81名全球专家(包括眼科、呼吸科和感染科医生)依据牛津医学证据等级生成初步共识声明。
关键数值与推荐
- 专家同意在结核性脉络膜炎患者中,任一免疫学试验阳性且影像学提示结核时启动抗结核治疗。
- 对于结核性匍行样脉络膜炎和结核瘤,即使无影像学提示结核,任一免疫学试验阳性也足以推荐抗结核治疗。
临床怎么用
- 临床医生可依据共识声明,结合免疫学试验和影像学结果,决定结核性脉络膜炎患者是否启动抗结核治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TOPIC: An international, expert-led consensus initiative organized by the Collaborative Ocular Tuberculosis Study (COTS), along with the International Ocular Inflammation Society and the International Uveitis Study Group, systematically developed evidence- and experience-based recommendations for the treatment of tubercular choroiditis. CLINICAL RELEVANCE: The diagnosis and management of tubercular uveitis (TBU) pose a significant challenge. Current guidelines and literature are insufficient to guide physicians regarding the initiation of antitubercular therapy (ATT) in patients with TBU. METHODS: An international expert steering subcommittee of the COTS group identified clinical questions and conducted a systematic review of the published literature on the use of ATT for tubercular choroiditis. Using an interactive online questionnaire, guided by background knowledge from published literature, 81 global experts (including ophthalmologists, pulmonologists, and infectious disease physicians) generated preliminary consensus statements for initiating ATT in tubercular choroiditis, using Oxford levels of medical evidence. In total, 162 statements were identified regarding when to initiate ATT in patients with tubercular serpiginous-like choroiditis, tuberculoma, and tubercular focal or multifocal choroiditis. The COTS group members met in November 2018 to refine these statements by a 2-step modified Delphi process. RESULTS: Seventy consensus statements addressed the initiation of ATT in the 3 subtypes of tubercular choroiditis, and in addition, 10 consensus statements were developed regarding the use of adjunctive therapy in tubercular choroiditis. Experts agreed on initiating ATT in tubercular choroiditis in the presence of positive results for any 1 of the positive immunologic tests along with radiologic features suggestive of tuberculosis. For tubercular serpiginous-like choroiditis and tuberculoma, positive results from even 1 positive immunologic test were considered sufficient to recommend ATT, even if there were no radiologic features suggestive of tuberculosis. DISCUSSION: Consensus guidelines were developed to guide the initiation of ATT in patients with tubercular choroiditis, based on the published literature, expert opinion, and practical experience, to bridge the gap between clinical need and available medical evidence.
引用
- Agrawal R, Testi I, Mahajan S, et al. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis. Ophthalmology. 2020. PMID: 32115264. doi:10.1016/j.ophtha.2020.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。